Porterfield, John E
- Bridgesource Medical Corporation (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,627
- Rising Star
- Top 10% Funded
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2018 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$3.2M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#1,627
By linked amount among FY2023 PIs
Earliest Year Loaded
2018
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Porterfield, John E as a PI. Multi-PI records show the full award amount for context.
- 5R44HL145847-03R44Contact PINative Hemodynamic Measurement as Feedback Control for Mechanical Cardiac Support$1.2Maward amount
- 2R44HL154960-02R44Contact PINovel Device to Optimize Aerosol Drug Delivery for Pulmonary Hypertension Treatment$1Maward amount
- 5R44AG074121-03R44Contact PITechnology-Enabled Financial Planning for Caregivers and Clients with Reduced Capacity$998.1Kaward amount
Award organization
Organizations that administered FY2023 awards listing Porterfield, John E as a PI.
FY2023 award administered by Bridgesource Medical Corporation (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2018First NIH AwardBridgesource Medical Corporation
- 2019$500K Cumulative Funding
- 2019$1M Cumulative Funding
- 2019Entered Top 50% NationallyRanked #9401
- 2022$2M Cumulative Funding
- 2023$5M Cumulative Funding
- 2023Entered Top 25% NationallyRanked #1627
- 2023Entered Top 10% NationallyRanked #1627